Phase II Multicenter Single-arm Study of BKM120 Plus Capecitabine for Breast Cancer Patients With Brain Metastases
Phase of Trial: Phase II
Latest Information Update: 20 May 2017
At a glance
- Drugs Buparlisib (Primary) ; Capecitabine
- Indications Breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 18 May 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
- 09 Nov 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov record.